Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 25 | 2025 | 552 | 7.760 |
Why?
|
| Lewy Body Disease | 12 | 2025 | 30 | 6.290 |
Why?
|
| Cognitive Dysfunction | 12 | 2025 | 391 | 4.210 |
Why?
|
| Sex Characteristics | 8 | 2025 | 769 | 2.620 |
Why?
|
| Alzheimer Disease | 8 | 2025 | 574 | 2.340 |
Why?
|
| Supranuclear Palsy, Progressive | 4 | 2025 | 18 | 1.920 |
Why?
|
| Neuropsychological Tests | 16 | 2025 | 1054 | 1.400 |
Why?
|
| Sexual and Gender Minorities | 2 | 2024 | 229 | 1.270 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 138 | 1.230 |
Why?
|
| Lewy Bodies | 4 | 2024 | 10 | 1.050 |
Why?
|
| Prodromal Symptoms | 1 | 2025 | 17 | 0.920 |
Why?
|
| Frontotemporal Dementia | 4 | 2025 | 57 | 0.850 |
Why?
|
| Tauopathies | 2 | 2023 | 13 | 0.840 |
Why?
|
| Brain | 7 | 2025 | 2790 | 0.780 |
Why?
|
| Cognition | 7 | 2025 | 1179 | 0.770 |
Why?
|
| Movement Disorders | 2 | 2022 | 64 | 0.690 |
Why?
|
| Social Determinants of Health | 1 | 2025 | 265 | 0.690 |
Why?
|
| Language | 3 | 2020 | 303 | 0.670 |
Why?
|
| Activities of Daily Living | 1 | 2024 | 419 | 0.670 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2020 | 19 | 0.670 |
Why?
|
| Memory, Short-Term | 2 | 2020 | 257 | 0.660 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 47 | 0.650 |
Why?
|
| Aged | 23 | 2025 | 24236 | 0.640 |
Why?
|
| Neural Pathways | 3 | 2023 | 304 | 0.640 |
Why?
|
| Caregivers | 4 | 2025 | 905 | 0.630 |
Why?
|
| Cognitive Aging | 1 | 2019 | 15 | 0.630 |
Why?
|
| Myoclonus | 1 | 2019 | 15 | 0.630 |
Why?
|
| Subthalamic Nucleus | 1 | 2020 | 78 | 0.620 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 6 | 0.600 |
Why?
|
| Dementia | 1 | 2023 | 264 | 0.600 |
Why?
|
| Hydrocephalus | 1 | 2019 | 110 | 0.570 |
Why?
|
| Deep Brain Stimulation | 1 | 2020 | 178 | 0.550 |
Why?
|
| Humans | 50 | 2025 | 139062 | 0.550 |
Why?
|
| Corpus Striatum | 1 | 2019 | 176 | 0.550 |
Why?
|
| Hyperkinesis | 1 | 2017 | 17 | 0.540 |
Why?
|
| Psycholinguistics | 1 | 2017 | 19 | 0.540 |
Why?
|
| Vocabulary | 1 | 2017 | 37 | 0.530 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 258 | 0.530 |
Why?
|
| Male | 30 | 2025 | 68324 | 0.520 |
Why?
|
| Affect | 1 | 2019 | 312 | 0.510 |
Why?
|
| Longitudinal Studies | 6 | 2025 | 2846 | 0.510 |
Why?
|
| Dopamine | 1 | 2019 | 309 | 0.500 |
Why?
|
| Female | 31 | 2025 | 74074 | 0.500 |
Why?
|
| Gait Disorders, Neurologic | 3 | 2023 | 46 | 0.480 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 449 | 0.470 |
Why?
|
| Anxiety | 2 | 2019 | 1069 | 0.450 |
Why?
|
| Disease Progression | 4 | 2025 | 2741 | 0.450 |
Why?
|
| Frontotemporal Lobar Degeneration | 2 | 2025 | 18 | 0.440 |
Why?
|
| Aged, 80 and over | 7 | 2025 | 7698 | 0.440 |
Why?
|
| REM Sleep Behavior Disorder | 2 | 2025 | 14 | 0.430 |
Why?
|
| Parkinsonian Disorders | 2 | 2025 | 43 | 0.420 |
Why?
|
| Phenotype | 2 | 2025 | 3160 | 0.410 |
Why?
|
| Middle Aged | 19 | 2025 | 33864 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2025 | 3651 | 0.390 |
Why?
|
| Databases, Factual | 2 | 2018 | 1404 | 0.380 |
Why?
|
| Sex Factors | 4 | 2025 | 2054 | 0.370 |
Why?
|
| Executive Function | 4 | 2025 | 453 | 0.340 |
Why?
|
| Neurofilament Proteins | 2 | 2025 | 51 | 0.280 |
Why?
|
| Basal Ganglia | 2 | 2024 | 57 | 0.260 |
Why?
|
| Semantics | 2 | 2017 | 95 | 0.260 |
Why?
|
| Smartphone | 2 | 2024 | 88 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 2514 | 0.250 |
Why?
|
| Multiple System Atrophy | 1 | 2025 | 8 | 0.230 |
Why?
|
| Language Disorders | 1 | 2025 | 30 | 0.230 |
Why?
|
| Support Vector Machine | 1 | 2025 | 38 | 0.230 |
Why?
|
| Age of Onset | 2 | 2025 | 519 | 0.230 |
Why?
|
| White Matter | 2 | 2024 | 144 | 0.230 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2025 | 154 | 0.210 |
Why?
|
| Substantia Nigra | 1 | 2024 | 58 | 0.210 |
Why?
|
| Restless Legs Syndrome | 1 | 2023 | 21 | 0.200 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2023 | 38 | 0.200 |
Why?
|
| Gender Identity | 1 | 2023 | 125 | 0.190 |
Why?
|
| Suicide, Assisted | 1 | 2022 | 26 | 0.180 |
Why?
|
| Patient Selection | 1 | 2025 | 692 | 0.180 |
Why?
|
| Attention | 1 | 2024 | 442 | 0.170 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2020 | 15 | 0.170 |
Why?
|
| Dopamine Agents | 1 | 2020 | 21 | 0.170 |
Why?
|
| Proteome | 1 | 2025 | 472 | 0.170 |
Why?
|
| Brain Mapping | 2 | 2022 | 524 | 0.160 |
Why?
|
| Cohort Studies | 4 | 2025 | 5736 | 0.160 |
Why?
|
| Memory | 2 | 2019 | 258 | 0.160 |
Why?
|
| Symptom Assessment | 1 | 2021 | 129 | 0.160 |
Why?
|
| Social Support | 1 | 2023 | 628 | 0.150 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2020 | 134 | 0.150 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 59 | 0.150 |
Why?
|
| Space Perception | 1 | 2019 | 81 | 0.150 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 100 | 0.150 |
Why?
|
| Motor Disorders | 1 | 2019 | 15 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2025 | 699 | 0.150 |
Why?
|
| Memory Disorders | 1 | 2019 | 176 | 0.140 |
Why?
|
| Educational Status | 1 | 2021 | 474 | 0.140 |
Why?
|
| Atrophy | 1 | 2019 | 189 | 0.140 |
Why?
|
| Irritable Mood | 1 | 2019 | 50 | 0.140 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 5537 | 0.140 |
Why?
|
| Mental Recall | 1 | 2019 | 206 | 0.140 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 305 | 0.140 |
Why?
|
| Visual Perception | 1 | 2019 | 171 | 0.140 |
Why?
|
| Turkey | 1 | 2017 | 21 | 0.140 |
Why?
|
| Reaction Time | 1 | 2019 | 421 | 0.140 |
Why?
|
| Healthy Aging | 1 | 2018 | 36 | 0.130 |
Why?
|
| Virtual Reality | 1 | 2018 | 65 | 0.130 |
Why?
|
| Iron | 1 | 2019 | 324 | 0.130 |
Why?
|
| Functional Laterality | 1 | 2018 | 232 | 0.130 |
Why?
|
| Psychomotor Performance | 1 | 2019 | 316 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2019 | 263 | 0.130 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 307 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 854 | 0.130 |
Why?
|
| Feeding and Eating Disorders | 1 | 2019 | 168 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 452 | 0.120 |
Why?
|
| Appendectomy | 1 | 2017 | 89 | 0.120 |
Why?
|
| Family | 1 | 2021 | 677 | 0.120 |
Why?
|
| Adult | 8 | 2025 | 38389 | 0.120 |
Why?
|
| Genotype | 1 | 2020 | 1873 | 0.120 |
Why?
|
| Movement | 1 | 2017 | 283 | 0.110 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 301 | 0.110 |
Why?
|
| Neurons | 1 | 2024 | 1606 | 0.110 |
Why?
|
| Nerve Net | 1 | 2018 | 268 | 0.110 |
Why?
|
| Gray Matter | 2 | 2025 | 81 | 0.110 |
Why?
|
| Age Factors | 1 | 2021 | 3273 | 0.100 |
Why?
|
| tau Proteins | 2 | 2025 | 95 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 5892 | 0.100 |
Why?
|
| Mutation | 2 | 2025 | 3999 | 0.100 |
Why?
|
| Biomarkers | 4 | 2025 | 4115 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3584 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2025 | 7660 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 1307 | 0.090 |
Why?
|
| Quality of Life | 1 | 2023 | 2954 | 0.090 |
Why?
|
| Headache Disorders | 1 | 2010 | 19 | 0.080 |
Why?
|
| Blood Patch, Epidural | 1 | 2010 | 20 | 0.080 |
Why?
|
| Intracranial Hypotension | 1 | 2010 | 56 | 0.080 |
Why?
|
| Functional Neuroimaging | 2 | 2018 | 59 | 0.070 |
Why?
|
| Gait | 2 | 2023 | 301 | 0.070 |
Why?
|
| United States | 1 | 2025 | 15065 | 0.070 |
Why?
|
| C9orf72 Protein | 1 | 2025 | 12 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2025 | 97 | 0.060 |
Why?
|
| United Kingdom | 1 | 2025 | 321 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 85 | 0.050 |
Why?
|
| Dopamine Agonists | 1 | 2023 | 42 | 0.050 |
Why?
|
| Social Stigma | 1 | 2025 | 143 | 0.050 |
Why?
|
| Hallucinations | 1 | 2023 | 32 | 0.050 |
Why?
|
| Focus Groups | 1 | 2025 | 533 | 0.050 |
Why?
|
| Impulsive Behavior | 1 | 2023 | 151 | 0.050 |
Why?
|
| Mobile Applications | 1 | 2024 | 178 | 0.040 |
Why?
|
| Arizona | 1 | 2021 | 80 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2025 | 1497 | 0.040 |
Why?
|
| Young Adult | 1 | 2017 | 13341 | 0.040 |
Why?
|
| Learning | 1 | 2023 | 420 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 1036 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 755 | 0.040 |
Why?
|
| Proteomics | 1 | 2025 | 1114 | 0.040 |
Why?
|
| Internet | 1 | 2023 | 674 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 1958 | 0.040 |
Why?
|
| Research | 1 | 2021 | 452 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4024 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 2864 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 3316 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 510 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2044 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 2080 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2018 | 15922 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 10426 | 0.010 |
Why?
|